FINANCING

Grovrito is currently working with a leading dermal contract research laboratory to conduct a demonstration proof of concept human trial. This is a limited trial which is expected to be completed by year end. The results, together with Grovrito’s IP portfolio, will be used to raise funds for the clinical development of our drug.